Safety and immunogenicity of a 30-valent M protein-based group a streptococcal vaccine in healthy adult volunteers: A randomized, controlled phase I study

Global, Regional, and National Burden of Rheumatic Heart Disease, 1990–2015

David Watkins, Catherine O. Johnson, Samantha Colquhoun et al. · New England Journal of Medicine · 2017 · 1.2K citations · Full text

Public Health, Cardiology, Epidemiology +16

A Systematic and Functional Classification of Streptococcus pyogenes That Serves as a New Tool for Molecular Typing and Vaccine Development

Martina Sanderson‐Smith, David M. P. De Oliveira, Julien Guglielmini et al. · The Journal of Infectious Diseases · 2014 · 317 citations · Full text

Life Sciences, Immunology, Microbiology +17

Safety and Immunogenicity of 26-Valent Group A Streptococcus Vaccine in Healthy Adult Volunteers

Shelly McNeil, Scott A. Halperin, Joanne M. Langley et al. · Clinical Infectious Diseases · 2005 · 305 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

DIFFERENTIATION OF GROUP A STREPTOCOCCI WITH A COMMON R ANTIGEN INTO THREE SEROLOGICAL TYPES, WITH SPECIAL REFERENCE TO THE BACTERICIDAL TEST

Rebecca C. Lancefield · The Journal of Experimental Medicine · 1957 · 289 citations · Full text

Life Sciences, Microbiology, Bacteriology +9

New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci

James B. Dale, Thomas A. Penfound, Edna Y. Chiang et al. · Vaccine · 2011 · 260 citations

Life Sciences, Immunology, Microbiology +17